2.10
price down icon0.94%   -0.02
after-market Handel nachbörslich: 2.15 0.05 +2.38%
loading
Schlusskurs vom Vortag:
$2.12
Offen:
$2.1
24-Stunden-Volumen:
411.01K
Relative Volume:
0.30
Marktkapitalisierung:
$290.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-6.00
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
+0.48%
1M Leistung:
+14.13%
6M Leistung:
+28.83%
1J Leistung:
+54.41%
1-Tages-Spanne:
Value
$2.06
$2.165
1-Wochen-Bereich:
Value
$2.06
$2.2299
52-Wochen-Spanne:
Value
$0.765
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
Firmenname
Compass Therapeutics Inc
Name
Telefon
617-500-8099
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CMPX's Discussions on Twitter

Vergleichen Sie CMPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMPX
Compass Therapeutics Inc
2.10 289.01M 0 -45.44M -42.28M -0.35
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-02 Hochstufung Leerink Partners Market Perform → Outperform
2025-02-24 Eingeleitet Guggenheim Buy
2025-02-19 Eingeleitet Piper Sandler Overweight
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-15 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2023-01-31 Eingeleitet Jefferies Buy
2023-01-27 Eingeleitet Stifel Buy
2022-05-23 Fortgesetzt H.C. Wainwright Buy
2022-03-15 Eingeleitet Ladenburg Thalmann Buy
2022-01-19 Eingeleitet B. Riley Securities Buy
2021-12-22 Eingeleitet Raymond James Outperform
2021-12-20 Eingeleitet SVB Leerink Outperform
2021-12-15 Eingeleitet Wedbush Outperform
Alle ansehen

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

pulisher
May 29, 2025

Northern Trust Corp Sells 43,164 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Insider Buying: Thomas Schuetz Acquires Additional Shares of Com - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO Acquires 10,000 Shares - TradingView

May 27, 2025
pulisher
May 22, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 19, 2025

Dimensional Fund Advisors LP Buys New Stake in Babcock & Wilcox Enterprises, Inc. (NYSE:BW) - Defense World

May 19, 2025
pulisher
May 19, 2025

Bell Investment Advisors Inc Buys 79 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Dark Forest Capital Management LP Cuts Stock Holdings in NVIDIA Co. (NASDAQ:NVDA) - Defense World

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 19, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Bought by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Ceera Investments LLC Grows Stock Position in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Apple Inc. (NASDAQ:AAPL) is Sound View Wealth Advisors Group LLC’s Largest Position - Defense World

May 19, 2025
pulisher
May 19, 2025

Frontier Asset Management LLC Acquires 1,041 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Rebalance LLC Grows Stake in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Ocugen, Inc. (NASDAQ:OCGN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Sells 5,102 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 16, 2025
pulisher
May 14, 2025

Spotlight On Three Promising Penny Stocks In May 2025 - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Acquires 13,038 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts Compass Therapeutics (NASDAQ:CMPX) Price Target to $10.00 - Defense World

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $279,000 Stock Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Mariner LLC Purchases New Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Guggenheim Adjusts Price Target for Compass Therapeutics (CMPX) - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics (CMPX) Price Target Lowered by Guggenheim | CMPX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Compass Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 06, 2025

Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Grows Stock Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 05, 2025
pulisher
May 05, 2025

Cholangiocarcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

May 05, 2025
pulisher
May 03, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.4% in April - Defense World

May 03, 2025
pulisher
May 02, 2025

Was Compass Therapeutics Inc (CMPX)’s session last reading good? - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

JPMorgan Chase & Co. Acquires 227,864 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 02, 2025
pulisher
Apr 29, 2025

Compass Therapeutics Inc’s Market Journey: Closing Weak at 1.90, Down -2.06 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Compass Therapeutics (NASDAQ:CMPX) Given Buy Rating at D. Boral Capital - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Compass Therapeutics (CMPX) Unveils Promising Data at AACR Annua - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Cardiol Therapeutics announces annual shareholder meeting By Investing.com - Investing.com UK

Apr 28, 2025
pulisher
Apr 28, 2025

Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Position Increased by Geode Capital Management LLC - Defense World

Apr 28, 2025
pulisher
Apr 27, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 27, 2025
pulisher
Apr 27, 2025

2 Penny stocks to buy in May 2025 - Finbold

Apr 27, 2025
pulisher
Apr 24, 2025

It is Poised to be a Bull Market for Compass Therapeutics Inc (CMPX) - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Compass Therapeutics (NASDAQ:CMPX) Earns Buy Rating from Guggenheim - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

What was Compass Therapeutics Inc (CMPX)’s performance in the last session? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Compass Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.2378: Will the Stock Break Through? - investchronicle.com

Apr 23, 2025
pulisher
Apr 22, 2025

Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from HC Wainwright - Defense World

Apr 22, 2025
pulisher
Apr 22, 2025

Compass Therapeutics (NASDAQ:CMPX) Given “Buy” Rating at D. Boral Capital - Defense World

Apr 22, 2025

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):